In order to find favorable candidates for immunotherapy, Hu et al. proposed a practical algorithm for efficiently extracting MMR-deficient PC cases, in which IHC or MSI testing is initially assigned to resected cases, and next-generation sequencing to metastatic/locally advanced cases [35]. This evidence concerns the gene MRC1 and pachyonychia congenita.